Related Experiment Video
Updated: Jul 20, 2026
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Prostate cancer nomograms: an update
Felix K-H Chun1, Pierre I Karakiewicz, Alberto Briganti
1Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada.
Objective:
Several nomograms have been developed to predict outcomes related to prostate cancer (PCa).
Methods:
We provide a descriptive and an analytic comparison of nomograms. Further, we report a set of recent PCa nomograms, in which we recorded predictor variables, number of patients used to develop each nomogram, and nomogram-specific features. Moreover, accuracy estimates and type of validation are considered.
Results:
Our findings suggest a demand for updated nomograms in selected fields of PCa outcomes. Moreover, an increasing number of nomograms address important end points such as prostate-specific antigen recurrence, distant metastases, or androgen-independent PCa-specific survival.
Conclusion:
Our results suggest that nomograms are available for many PCa-related outcomes. They represent a valid methodologic approach if correct criteria are met.
